Captor Therapeutics ® Investor Relations

      Investor Relations

      Dates of publication of periodic reports in 2022

      Publication date: 2022-01-26
      Number: RB ESPI 6/2022

      Current Report No. 6/2022

      Date of preparation: 26 January 2022

      Subject: Dates of publication of periodic reports in 2022

      Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information

      The Management Board of Captor Therapeutics S.A. with its registered office in Wroclaw (the “Company”) discloses to the public the dates of publication of periodical reports in the fiscal year 2022:

      • 29 April 2022 - separate annual report and consolidated annual report for 2021 ;
      • 26 May 2022 - consolidated quarterly report for Q1 2022;
      • 22 September 2022 - consolidated semi-annual report for the first half of 2022;
      • 24 November 2022 - consolidated quarterly report for Q3 2021.

      At the same time, the Company announces that:

      • pursuant to § 62 sec. 1 of the Regulation of the Minister of Finance of 29 March 2018 on current and periodic information published by issuers of securities and the conditions for recognizing as equivalent information required by the laws of a non-member state (the "Regulation"), it will not publish separate quarterly reports; as a result, the extended consolidated quarterly reports will include quarterly financial information, referred to in § 62 sec. 1 of the Regulation;
      • pursuant to § 62 sec. 3 of the Regulation, it will not publish separate semi-annual reports; consequently, the extended consolidated semi-annual report will include abridged semi-annual financial statements, referred to in § 62 sec. 3 of the Regulation, together with the report of the entity authorized to audit financial statements and abridged additional information;
      • pursuant to § 79 section 2 of the Regulation, it will not publish separate and quarterly reports, including the extended consolidated quarterly report, for Q2 and Q4 for 2022.